Hyperphosphorylation of the protein tau, a MAP linked with neurodegeneration, promotes destabilization of microtubules in Alzheimer's disease which makes MAPs promising targets for therapeutic approaches to Alzheimer's disease [4]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.